Alpha-1 Research Program
The Alpha-1 Research Program was established at the University of Florida College of Medicine in 1998 by the Alpha-1 Foundation. The Program, under the direction of Mark L. Brantly, M.D., is devoted to the study of lung and liver disease associated with alpha-1 antitrypsin (AAT) Deficiency. Its resources and services are an important access point for the national and international medical and scientific communities.
Alpha-1
patients
The UF Alpha-1 Specialty Clinic provides consultation and care for patients that have been diagnosed with alpha-1 antitrypsin deficiency.
Laboratory research
Alpha-1 Translation Research Lab
Devoted to characterizing the molecular responsible for the development of liver and lung disease in alpha-1 antitrypsin deficient individuals.
Human research
Clinical Research
The Alpha-1 Research Program has developed a team of scientists, nurses, and administrators to conduct a number of clinical trials and other research projects for individuals who have AAT deficiency.
Partnerships
The Alpha-1 Foundation DNA and Tissue Bank serves the international scientific community with a collection of DNA and tissue samples for researchers.